Delivery Order 36F79720D0097-36C24726F0062
Award Date 4/1/26
Potential Completion Date 3/31/31
Potential Value $451K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Augusta, GA 30904, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, was awarded a $692,149.52 firm fixed-price delivery order by Veterans Integrated Service Network 6 (VISN 6) on May 13, 2022, for the provision of ExoDx Prostate (IntelliScore) testing services. The contract, which is a child award under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), requires performance through September 30, 2026, at the Richmond, VA location. This non-invasive,...
- Exosome Diagnostics Inc., a Bio-Techne Corporation subsidiary based in Waltham, Massachusetts, received a delivery order award from Veterans Integrated Service Network (VISN) 7 on April 1, 2021, for its ExoDx Prostate (IntelliScore) diagnostic testing services. The delivery order, valued at $438,951.68 on a firm fixed-price basis, is issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and does not utilize a set-aside designation. Performance...
- Exosome Diagnostics Inc., a Bio-Techne Corporation subsidiary based in Waltham, Massachusetts, received a $69,891.36 firm fixed-price task order from the Department of Veterans Affairs Veterans Integrated Service Network 1 (VISN 1) for ExoDx Prostate IntelliScore testing services. This contract, awarded January 15, 2024, with completion by December 14, 2024, represents a child task order issued against the company's parent Blanket Purchase Agreement valued at $1.35M. The ExoDx Prostate...
- Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, was awarded a $384,026.72 firm fixed-price delivery order by Veterans Integrated Service Network 2 on October 1, 2024, for ExoDx Prostate Test IntelliScore biopsies at the Northport VA Medical Center in New York. The contract, which is a child award under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), carries an ultimate completion date of September 30, 2029, and involves no set-aside...
- Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, received a Blanket Purchase Agreement (BPA) call valued at $103,709.76 from Veterans Integrated Service Network 1 (VISN 1), a component of the Department of Veterans Affairs. The award, issued on December 15, 2024, is for the provision of ExoDx Prostate IntelliScore testing services, a non-invasive, urine-based liquid biopsy diagnostic test that analyzes exosomal RNA biomarkers to assess the risk of clinically significant prostate...
- This is a $9,018.24 firm fixed price purchase order awarded to Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 4 (VISN 4). The contract is for TESTING services, with a period of performance through December 11, 2024. There is no set-aside designation indicated. Exosome Diagnostics is a provider of liquid biopsy tests and laboratory services, primarily focused on non-invasive cancer detection and...
- This federal contract award is for the EXOSOME DX TESTING service provided by Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation. The $37,576.00 firm-fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) under the Medical Laboratory Testing and Analysis Services GSA Schedule contract. The contract supports the VA's prostate cancer screening initiatives for veterans, with Exosome Diagnostics supplying its ExoDx Prostate IntelliScore liquid biopsy test,...
- This is a Year 3 task order issued against a parent Blanket Purchase Agreement (BPA) held by Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation specializing in advanced liquid biopsy diagnostic technologies. The task order, valued at $270K and awarded December 15, 2025, by Veterans Integrated Service Network 1 (VISN 1) under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), will deliver approximately 360 ExoDx Prostate IntelliScore tests...
- This is a $8,266.72 firm fixed price delivery order contract awarded to Exosome Diagnostics, Inc., a subsidiary of Bio-Techne Corporation, by the U.S. Department of Veterans Affairs (VA). The contract is for the provision of the ExoDx Prostate (IntelliScore) non-invasive, urine-based liquid biopsy test to support prostate cancer screening for veterans at the Northport VA Medical Center. This contract was awarded under the VA's Medical Laboratory Testing and Analysis Services Federal Supply...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, a $0.00 firm fixed price delivery order against the Medical Laboratory Testing and Analysis Services (FSS-621-II) GSA Schedule. The order is for EXO DX OPTION YR 1 services with a period of performance through September 30, 2022. No set-aside designation was used for this award. Exosome Diagnostics will provide...